Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection

Myasthenia gravis (MG) is an autoimmune neuromuscular transmission disorder characterized by loss of acetylcholine receptors (AChR’s) due primarily to the production of anti-AChR autoantibodies. In this study we investigated whether the presence of decay-accelerating factor (DAF or CD55), an intrins...

Descrición completa

Detalles Bibliográficos

Publicado en:	J Clin Invest
Principais autores:	Lin, Feng, Kaminski, Henry J., Conti-Fine, Bianca M., Wang, Wei, Richmonds, Chelliah, Medof, M. Edward
Formato:	Artigo
Idioma:	Inglês
Publicado:	American Society for Clinical Investigation 2002
Assuntos:	Article
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC151616/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12417565/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI16086
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!